ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ACAD Acadia Pharmaceuticals Inc

17.08
0.03 (0.18%)
Fuera de horario
Última actualización: 17:30:03
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Acadia Pharmaceuticals Inc ACAD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.03 0.18% 17.08 17:30:03
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
16.94 16.81 17.38 17.08 17.05
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202415:16BWAcadia Pharmaceuticals is Proud to Announce the Winners of..
24/4/202415:05BWAcadia Pharmaceuticals to Announce First Quarter Financial..
22/4/202408:04BWAcadia Pharmaceuticals Announces Trofinetide New Drug..
19/4/202415:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
17/4/202415:05BWAcadia Pharmaceuticals Presents New DAYBUE™ (trofinetide)..
02/4/202415:05BWAcadia Appoints Elizabeth H. Z. Thompson, Ph.D. as Executive..
01/4/202415:05BWAcadia Pharmaceuticals to Participate in the 23rd Annual..
15/3/202415:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
13/3/202415:05BWAcadia Pharmaceuticals to Participate in the UBS Virtual CNS..
12/3/202406:21IHMARKETNEWSOracle Soars 13% With Exceptional Growth and Boosts Nvidia..
11/3/202415:05EDGAR2Form 8-K - Current report
11/3/202415:05BWAcadia Pharmaceuticals Announces Top-Line Results from Phase..
29/2/202408:05BWAcadia Pharmaceuticals to Participate in TD Cowen’s 44th..
27/2/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:16EDGAR2Form 8-K - Current report
27/2/202415:05BWAcadia Pharmaceuticals Reports Fourth Quarter and Full Year..
21/2/202415:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
14/2/202406:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202415:05BWAcadia Pharmaceuticals to Announce Fourth Quarter and Full..
08/2/202416:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202416:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/1/202420:55EDGAR2Form 8-K - Current report
30/1/202419:48BWAcadia Announces Additions to Executive Team
26/1/202416:25EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/1/202415:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
18/1/202415:05BWAcadia Announces the Passing of Former President Srdjan..
09/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:05BWAcadia Pharmaceuticals to Present at the 42nd Annual J.P...
18/12/202315:05BWAcadia Pharmaceuticals Reports Inducement Grants Under..
15/12/202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202311:46EDGAR2Form 144 - Report of proposed sale of securities
14/12/202304:59IHMARKETNEWSApple Stocks Reach Record, Adobe Faces Stock Drops,..
13/12/202320:24BWDelaware District Court Rules in Favor of Acadia on..
13/12/202312:41BWDelaware Federal District Court Rules in Favor of Acadia..
30/11/202308:05BWAcadia Pharmaceuticals Initiates Pivotal Phase 3 Study of..
28/11/202316:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202308:05BWAcadia Pharmaceuticals Initiates Phase 2 Clinical Trial of..
21/11/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202316:11EDGAR2Form 8-K - Current report
21/11/202316:00BWAcadia Pharmaceuticals Announces Change in Research and..
14/11/202315:12BWAcadia Pharmaceuticals Reports Inducement Grants Under..
02/11/202315:21EDGAR2Form 8-K - Current report
02/11/202315:05BWAcadia Pharmaceuticals Reports Third Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock